Drug Profile
Research programme: inflammation and pain therapeutic - UMeWorld
Alternative Names: ARX-8203Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator AlphaRx
- Developer Gaia BioPharma; UMeWorld
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Gout; Ocular inflammation; Postoperative pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gout in Canada (PO, Capsule)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Ocular-inflammation in Canada (Ophthalmic)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Postoperative-pain in Canada (Parenteral, Injection)